SmartKem, Inc.
Business
SmartKem, Inc. develops and commercializes TRUFLEX® organic semiconductor materials and processes for low-temperature printed thin-film transistors (OTFTs) aimed primarily at the display industry. It supplies formulated ink sets and interlayer dielectric materials, associated process-of-records, prototyping and device design consultancy, and intends to offer foundry services via partners. Its business is organized around materials R&D and formulation, prototyping and manufacturing process transfer (via partners such as CPI and ITRI), and EDA/tool development. SmartKem targets display OEMs and advanced packaging customers globally, with initial sales focus in Taiwan, South Korea, Japan and China via direct sales, collaborations, and partner foundries.
Summary from filing dated 2025-03-31
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 697,000 | 82,000 | 27,000 | 40,000 | 18,000 | |
| Cost of revenue | 272,000 | 32,000 | 23,000 | 33,000 | 8,000 | |
| Gross profit | 425,000 | 50,000 | 4,000 | 7,000 | 10,000 | |
| Other operating income | 951,000 | 1 | 800,000 | 1 | 1 | |
| Research and development | 7 | 5 | 6 | 6 | 8 | |
| General and administrative | 7 | 6 | 5 | 5 | 8 | |
| (Gain) / loss on foreign currency transactions | −177,000 | 78,000 | 87,000 | — | — | |
| Total operating expenses | 14 | 12 | 11 | 11 | 18 | |
| Loss from operations | −13 | −10 | −10 | −10 | −16 | |
| Gain / (loss) on foreign currency transactions | 2 | −544,000 | 1 | −2 | — | |
| Change in fair value of the warrant liability | — | 672,000 | 465,000 | — | — | |
| Interest income / (expense) | −73,000 | 7,000 | 12,000 | — | — | |
| Total non-operating income / (expense) | 2 | 135,000 | 1 | −2 | −824,000 | |
| Loss before income taxes | −11 | −10 | −8 | −11 | −17 | |
| Income tax refund / (expense) | 24,000 | −1,000 | — | −24,000 | — | |
| Net loss | −11 | −10 | −9 | −12 | −17 | |
| Preferred stock deemed dividends | — | −9 | — | — | — | |
| Net loss attributed to common stockholders | −11 | −20 | −8 | — | — | |
| Basic net loss per common share (in dollars per share) | −1.29 | −3.17 | −6.32 | −13.88 | −0.68 | |
| Weighted average shares outstanding - basic (in shares) | 8 | 3 | 1 | 827,906 | 25 | |
| Diluted net loss per common share (in dollars per share) | −1.29 | −6 | −6.32 | −13.88 | −0.68 | |
| Weighted average shares outstanding -diluted (in shares) | 8 | 3 | 1 | 827,906 | 25 | |
| Dividends per common share (in dollars per share) | — | −2.83 | — | — | — | |
| Foreign currency translation | −2 | 473,000 | −1 | 880,000 | 117,000 | |
| Total comprehensive loss | −13 | −10 | −10 | −11 | −17 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 400,000 | 7 | 9 | 4 | 12 | |
| Accounts receivable | 3,000 | — | 268,000 | 30,000 | — | |
| Research and development tax credit receivable | 500,000 | 500,000 | 600,000 | 1 | 1 | |
| Prepaid expenses and other current assets | 575,000 | 849,000 | 811,000 | 1 | 802,000 | |
| Total current assets | 2 | 9 | 11 | 6 | 14 | |
| Property, plant and equipment, net | 180,000 | 269,000 | 455,000 | 602,000 | 802,000 | |
| Right-of-use assets, net | 607,000 | 120,000 | 285,000 | 475,000 | 154,000 | |
| Other assets, non-current | — | 6,000 | 7,000 | 6,000 | 6,000 | |
| Total assets | 2 | 9 | 11 | 8 | 15 | |
| Accounts payable and accrued expenses | 5 | 2 | 1 | 931,000 | 1 | |
| Lease liabilities, current | 271,000 | 47,000 | 230,000 | 206,000 | 87,000 | |
| Notes payable, current | 928,000 | — | — | — | — | |
| Other current liabilities | 108,000 | 450,000 | 360,000 | 244,000 | — | |
| Total current liabilities | 6 | 2 | 2 | 1 | 2 | |
| Lease liabilities, non-current | 312,000 | 25,000 | 19,000 | 239,000 | 28,000 | |
| Total liabilities | 6 | 2 | 3 | 2 | 2 | |
| Contingencies (Note 7) | — | — | — | — | — | |
| Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized, 0 and 856 shares issued and outstanding, at December 31, 2025 and December 31, 2024, respectively | — | — | — | — | — | |
| Common stock, par value $0.0001 per share, 300,000,000 shares authorized, 6,836,689 and 3,590,217 shares issued and outstanding, at December 31, 2025 and December 31, 2024, respectively | 1,000 | — | — | — | 3,000 | |
| Additional paid-in capital | 125 | 122 | 105 | 93 | 90 | |
| Accumulated other comprehensive loss | −4 | −1 | −2 | −483,000 | −1 | |
| Accumulated deficit | −125 | −115 | −95 | −87 | −75 | |
| Total stockholders' (deficit) / equity | −4 | 7 | 8 | 6 | 14 | |
| Total liabilities and stockholders' (deficit) / equity | 2 | 9 | 11 | 8 | 15 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net loss | −11 | −10 | −8 | −11 | −17 | |
| Depreciation | 212,000 | 258,000 | 145,000 | 198,000 | 209,000 | |
| Stock-based compensation expense | 1 | 850,000 | 717,000 | 488,000 | 6 | |
| Issuance of common stock to vendor | 1 | 253,000 | 55,000 | 391,000 | 263,000 | |
| Right-of-use asset amortization | 205,000 | 268,000 | 263,000 | 264,000 | 234,000 | |
| (Loss) / gain on foreign currency transactions | −3 | 647,000 | −1 | 2 | — | |
| Debt discount amortization | 87,000 | — | — | — | — | |
| Accounts receivable | −3,000 | 269,000 | −231,000 | −32,000 | 19,000 | |
| Research and development tax credit receivable | −29,000 | 84,000 | 562,000 | −213,000 | −104,000 | |
| Prepaid expenses and other assets | 268,000 | −33,000 | 70,000 | −42,000 | −532,000 | |
| Accounts payable and accrued expenses | 3 | 504,000 | 459,000 | −385,000 | 579,000 | |
| Lease liabilities | −182,000 | −281,000 | −266,000 | −265,000 | −276,000 | |
| Other current liabilities | −342,000 | 87,000 | 98,000 | 238,000 | — | |
| Net cash used in operating activities | −8 | −8 | −8 | −9 | −10 | |
| Purchases of property, plant and equipment | −123,000 | −75,000 | −18,000 | −79,000 | −341,000 | |
| Net cash used by investing activities | −123,000 | −75,000 | −18,000 | −79,000 | −341,000 | |
| Payment of issuance costs | — | −1 | −1 | −170,000 | −2 | |
| Proceeds from the issuance of debt | 1 | — | — | — | — | |
| Proceeds from the exercise of warrants | — | 24,000 | 25,000 | — | — | |
| Net cash provided by financing activities | 1 | 7 | 13 | 2 | 22 | |
| Effect of exchange rate changes on cash | 92,000 | −56,000 | −35,000 | −693,000 | — | |
| Net change in cash | −7 | −2 | 5 | −8 | 11 | |
| Right-of-use asset and lease liability additions | 708,000 | 82,000 | 50,000 | 583,000 | 136,000 | |
| Cash paid for income taxes | −24,000 | 1,000 | — | — | — |